Clinical Trials Logo
  1. Home
  2. Tourette's Syndrome
  3. NCT01475383

Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome

Tourette's Syndrome Clinical Trial

Official title:
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study Of The Safety And Efficacy Of PF-03654746 In Adults With Tourette's Syndrome

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of an investigational compound designated PF-03654746 compared to placebo in the treatment of adults with Tourette's Syndrome. The study will also explore the pharmacokinetics of PF-03654746 in adults with Tourette's Syndrome.

Clinical Trial Description

The study was terminated 11-Apr-2012 due to an internal reassessment of priorities by the sponsor. The decision to terminate was not based on any safety or efficacy concerns. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01475383
Study type Interventional
Source Pfizer
Contact
Status Withdrawn
Phase Phase 2
Start date April 2012
Completion date April 2012
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT00965211 - Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for the Treatment of Tourette Syndrome N/A
Recruiting NCT00152750 - Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD Phase 4
Completed NCT00241176 - Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 4
Terminated NCT00226824 - Safety Study of Galantamine in Tic Disorders Phase 4
Completed NCT01244633 - Ecopipam Treatment of Tourette Syndrome Phase 1/Phase 2
Recruiting NCT04805385 - Effects of Lactobacillus Plantarum PS128 in Patients With Tourette's Syndrome N/A
Completed NCT00026000 - Brain Activation in Vocal and Motor Tics N/A
Terminated NCT00001260 - Brain Tissue Collection for Neuropathological Studies
Completed NCT02102698 - Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years Phase 2
Withdrawn NCT02112253 - Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome Phase 1/Phase 2
Withdrawn NCT01133353 - A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome Phase 2
Completed NCT02205918 - Brain-Behavior Interactions in Tic Suppression
Terminated NCT00282139 - Aripiprazole in the Treatment of Tourette's Syndrome N/A
Completed NCT03042507 - Psychosocial Intervention for Young Children With Chronic Tics N/A
Completed NCT01019343 - Physiological Investigations of Movement Disorders N/A
Completed NCT02619084 - Subthalamic Stimulation in Tourette's Syndrome Phase 2
Completed NCT00368433 - Hypersensitivity in Tourette Syndrome N/A
Not yet recruiting NCT06361004 - Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome N/A
Completed NCT00139308 - High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome Phase 1